Search

everythinglearnresearchcommunity

for

Search:↓

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

ILC1-like cells may contribute to hair loss in alopecia areata.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

Wound healing can help prevent hair loss from chemotherapy in young rats by increasing interleukin-1β signaling.

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

Finasteride significantly increases scalp hair and prevents hair loss in young and middle-aged men.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Fetal skin has unique immune cells different from adult skin.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.